<p>Novel Alternatively Spliced Variants of Smad4 Expressed in TGF-β-Induced EMT Regulating Proliferation and Migration of A549 Cells</p>

Abstract

Introduction: Non-small cell lung cancer (NSCLC) is a worldwide malignance threatening human life. TGF-β/Smad signaling is known to regulate cell proliferation, differentiation, migration and growth. As the only co-Smad playing crucial roles in TGF-β signaling, Smad4 is reported to be frequently mutated or to occur as alternatively spliced in tumor cells. Smad4 was reported to be involved in the TGF-β-induced EMT process. However, whether the alternative splicing occurs in the TGF-β-induced EMT process in NSCLC was not clear. Methods: In our current study, we explored the alternative splicing of Smad4 during the process of TGF-β-induced EMT in A549 cells. 10 ng/mL TGF-β was used to induce EMT. Then, nest-PCR and agarose electrophoresis were performed to detect the expression of Smad4 variants and sequencing to get the variant DNA sequences. For recombinant expression of variants of Smad4 in A549 cells, we used lentiviral variants to infect cells. In order to explore the effects of variants on the proliferation and migration of A549 cells, the MTT assay, colony formation assay and wound-healing assay were done. The effects of variants on E-cad and VIM protein expression were explored through Western blot. Results: There were several novel gene fragments expressed in TGF-β-induced A549 cells, and the sequencing results showed that they were indeed the Smad4 variants that were not reported. For recombinant expression of Smad4 variants in A549 cells, we found that they have significant effects on the proliferation and migration of cells, and also regulated the E-cad and VIM protein expression. Conclusion: Our results indicated that novel Smad4 variants were expressed in TGF-βinduced EMT process. The functional study showed that these novel variants regulate cell proliferation and migration and affect E-cad and VIM protein expression, showing the potential as targets for cancer therapy.

Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review

“…So, suppressing TGF-β can ameliorate inflammation and fibrosis in lung epithelial cells. It has been reported that TGF-β alleviates development of ovarian hyperstimulation syndrome via VEGF overexpression ( Wan et al, 2020 ). These studies obviously demonstrate the role of TGF-β in diseases.…”

MiR-146a-5p targeting SMAD4 and TRAF6 inhibits adipogenensis through TGF-β and AKT/mTORC1 signal pathways in porcine intramuscular preadipocytes

“…SMAD4 is an important transmission medium that transduces extracellular signals, including TGF-β and BMP, to the nucleus [13][14][15]. It has been reported in the literature that SMAD4 regulates the proliferation and migration of A549 cells [16], dihydromyricetin inhibits the proliferation of human choriocarcinoma JAR cells via downregulation of SMAD4 expression [17], and miR-224 mediates the proliferation of HCT116 cells by targeting SMAD4 [18]. Although SMAD4 has been discovered and studied in the proliferation of different cell types, it needs to be further explored whether SMAD4 is implicated in proliferation of porcine intramuscular preadipocytes.…”

Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis

“…Briefly, TGF-β1 at 10 ng/mL was used to stimulate A549 cells for 72 hours. 28 We found that TGF-β1 treatment changed the morphology of A549 cells, which became large and long ( Figure 9A ). In contrast, 50 µM of AS-IV significantly improved the morphological changes of the cells.…”